ZURA ZURA BIO LTD revenue, earnings and financials
For the quarter ended June 30, 2026, ZURA BIO LTD reported revenue of n/a, net income of −$26.3M and diluted EPS of −$0.21; for the fiscal year ended December 2025 revenue was n/a.
ZURA annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$75.2M, net income −$68.7M (margin n/a), EPS −$1.06
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$55.2M, net income −$52.4M (margin n/a), EPS −$0.60
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$62.6M, net income −$60.4M (margin n/a), EPS −$2.09
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$2.68M, net income −$25.7M (margin n/a), EPS −$141.97
ZURA quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$26.3M, EPS −$0.21
- Quarter ended Mar 31, 2026: revenue n/a, net income −$24.2M, EPS −$0.22
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$17.2M, EPS −$0.49
- Quarter ended Sep 30, 2025: revenue n/a, net income −$18.0M, EPS −$0.21
- Quarter ended Jun 30, 2025: revenue n/a, net income −$16.0M, EPS −$0.17
- Quarter ended Mar 31, 2025: revenue n/a, net income −$17.4M, EPS −$0.19
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$13.6M, EPS −$0.15
- Quarter ended Sep 30, 2024: revenue n/a, net income −$20.7M, EPS −$0.26
- Quarter ended Jun 30, 2024: revenue n/a, net income −$10.3M, EPS −$0.17
- Quarter ended Mar 31, 2024: revenue n/a, net income −$7.75M, EPS −$0.02
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$8.47M, EPS $2.16
- Quarter ended Sep 30, 2023: revenue n/a, net income −$8.27M, EPS −$0.18
- Quarter ended Jun 30, 2023: revenue n/a, net income −$34.0M, EPS −$1.31
- Quarter ended Mar 31, 2023: revenue n/a, net income −$9.59M, EPS −$2.76
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$31.5M, EPS $72265.92
- Quarter ended Sep 30, 2022: revenue n/a, net income −$1.10M, EPS −$2.87
- Quarter ended Jun 30, 2022: revenue n/a, net income −$925K, EPS −$9.54
- Quarter ended Mar 31, 2022: revenue n/a, net income $7.80M, EPS −$72395.48
- Quarter ended Sep 30, 2021: revenue n/a, net income $5.79M, EPS n/a
- Quarter ended Jun 30, 2021: revenue n/a, net income −$19.1K, EPS −$0.01
ZURA cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$64.8M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$28.1M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$15.1M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$1.07M, share buybacks n/a
ZURA balance sheet
- Jun 30, 2026: cash $205M, total assets $213M, total liabilities $16.3M, shareholders' equity n/a
- Mar 31, 2026: cash $226M, total assets $229M, total liabilities $11.7M, shareholders' equity n/a
- Dec 31, 2025: cash $109M, total assets $114M, total liabilities $12.4M, shareholders' equity $102M
- Sep 30, 2025: cash $139M, total assets $144M, total liabilities $25.5M, shareholders' equity $108M
- Jun 30, 2025: cash $154M, total assets $158M, total liabilities $18.7M, shareholders' equity $126M
- Mar 31, 2025: cash $171M, total assets $172M, total liabilities $21.1M, shareholders' equity $138M
- Dec 31, 2024: cash $176M, total assets $180M, total liabilities $19.5M, shareholders' equity $147M
- Sep 30, 2024: cash $188M, total assets $189M, total liabilities $18.2M, shareholders' equity $153M
Is ZURA profitable?
No. ZURA BIO LTD lost $85.7M over the last four quarters.
What is ZURA's EPS?
Diluted earnings per share over the last four quarters were −$1.13; −$0.21 in the latest quarter.